Titlebook: Outcome Measures and Metrics in Systemic Lupus Erythematosus; Zahi Touma Book 2021 Springer Nature Switzerland AG 2021 Anxiety, depression

高调

Clinical Aspects of Systemic Lupus Erythematosus,an awareness and appreciation of the protean manifestations of SLE is an imperative for the lupus doctor as well as those involved in lupus research. We attempt a broad discussion of these manifestations in this chapter.

radiograph

Metrics of Damage in SLE, consideration include incorporation of novel descriptors, further psychometric testing of current SDI descriptors, a weighted scoring approach to items, and identifying items attributable to glucocorticoid use.

Project

侵略主义

轻浮思想

plasma-cells

Diagnosis and Classification of Systemic Lupus Erythematosus,discuss the development of the 2019 EULAR/ACR classification criteria for SLE. We highlight many insights gained about the current thinking around the construct of SLE and implications for SLE diagnosis.

非实体

Metrics and Outcome Measures of Disease Activity and Damage in Childhood-Onset Systemic Lupus Erythal disease activity and damage metrics, as well as health-related quality of life indices have been developed as means of monitoring disease in an effort of adjusting therapy accordingly. This chapter focuses on disease metrics and outcome measures validated for use in cSLE.

amnesia

garrulous

Book 2021f SLE is comprehensive and includes different core set domains; disease activity, damage, health-related quality of life, adverse events and economic impact. . This comprehensive book is focused on the instruments and outcome measures utilized in the assessment of SLE. It targets different audiences

Rinne-Test

Introduction: Metrics and Domains Measured in SLE,in particular cognition, depression, and anxiety as well as fatigue. Having explored what needs to be measured in SLE, this chapter then outlines the decision-making process by which candidate instruments are identified and determined to be a match for the target construct (e.g., disease activity).